Cargando…
Comment on Casiraghi et al. “Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis” 2020, 12, 211
In their article, Casiraghi, A. et al. describe a few relevant methods to assess the quality of a pharmaceutical preparation of oral viscous budesonide, intended to be swallowed, and treat the esophagus in eosinophilic esophagitis patients. They choose the following methods for this purpose: rheolog...
Autor principal: | Zur, Eyal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558643/ https://www.ncbi.nlm.nih.gov/pubmed/32878016 http://dx.doi.org/10.3390/pharmaceutics12090829 |
Ejemplares similares
-
Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211”
por: Casiraghi, Antonella, et al.
Publicado: (2020) -
Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis
por: Casiraghi, Antonella, et al.
Publicado: (2020) -
Comments to the Editor Re: Papukashvili et al. Nutrients 2020, 12, 184
por: Willson, Cyril
Publicado: (2020) -
Response to Collinson et al. Comment
por: Belmonte, Miriam, et al.
Publicado: (2020) -
Reply to formal comment on Griffiths et al. (2017) submitted by Gajewski (2020)
por: Griffiths, Katherine, et al.
Publicado: (2021)